SCHEMBL30463273

SCHEMBL30463273

CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(N)=O

nearest known ligand 0.59

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SIRT5 Q9NXA8 3/20 0.59
NPY4R P50391 9/20 0.43
NPY5R Q15761 6/20 0.43
NPY1R P25929 6/20 0.43
NPY2R P49146 3/20 0.43
FOLH1 Q04609 1/20 0.43
GNPAT O15228 1/20 0.43
TFPI P10646 1/20 0.42
KISS1R Q969F8 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.40
ALB P02768 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13166808 1.00 SIRT5 (0.59) SIRT5NPY4RNPY5RNPY1RNPY2R
SCHEMBL13701341 0.96 SIRT5 (0.63) SIRT5NPY4RNPY5RNPY1RNPY2R
SCHEMBL13166806 0.96 SIRT5 (0.55) SIRT5NPY4RNPY5RNPY1RNPY2R
SCHEMBL15856928 0.95 SIRT5 (0.54) SIRT5NPY4RNPY5RNPY1RNPY2R
SCHEMBL19084576 0.95 SIRT5 (0.54) SIRT5NPY4RNPY5RNPY1RNPY2R
SCHEMBL31157716 0.94 SIRT5 (0.53) SIRT5NPY4RNPY5RNPY1RNPY2R
SCHEMBL30463261 0.94 SIRT5 (0.53) SIRT5NPY4RNPY5RNPY1RNPY2R
SCHEMBL30463243 0.94 SIRT5 (0.53) SIRT5NPY4RNPY5RNPY1RNPY2R
SCHEMBL12066140 0.93 SIRT5 (0.53) SIRT5NPY4RNPY5RNPY1RNPY2R
SCHEMBL31157760 0.93 SIRT5 (0.53) SIRT5NPY4RNPY5RNPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230190616-A1 COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES LUBRIZOL ADVANCED MATERIALS, INC. (US) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230190616-A1 COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES GLA, ALG3, ANXA6 SIRT5 3611/4885NPY4R 397/4885NPY5R 247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.